Bethesda proposals for classification of lymphoid neoplasms in mice - PubMed (original) (raw)

Guideline

. 2002 Jul 1;100(1):246-58.

doi: 10.1182/blood.v100.1.246.

Affiliations

• PMID: 12070034
• DOI: 10.1182/blood.v100.1.246

Free article

Guideline

Bethesda proposals for classification of lymphoid neoplasms in mice

Herbert C Morse 3rd et al. Blood. 2002.

Free article

Abstract

A consensus system for classification of mouse lymphoid neoplasms according to their histopathologic and genetic features has been an elusive target for investigators involved in understanding the pathogenesis of spontaneous cancers or modeling human hematopoietic diseases in mice. An international panel of scientists with expertise in mouse and human hematopathology joined with the hematopathology subcommittee of the Mouse Models for Human Cancers Consortium to develop criteria for definition and classification of these diseases together with a standardized nomenclature. The fundamental elements contributing to the scheme are clinical features, morphology, immunophenotype, and genetic characteristics. The resulting classification has numerous parallels to the World Health Organization classification of human lymphoid tumors while recognizing differences that may be species specific. The classification should facilitate communications about mouse models of human lymphoid diseases.

PubMed Disclaimer

Similar articles

• Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice.
  Kogan SC, Ward JM, Anver MR, Berman JJ, Brayton C, Cardiff RD, Carter JS, de Coronado S, Downing JR, Fredrickson TN, Haines DC, Harris AW, Harris NL, Hiai H, Jaffe ES, MacLennan IC, Pandolfi PP, Pattengale PK, Perkins AS, Simpson RM, Tuttle MS, Wong JF, Morse HC 3rd; Hematopathology subcommittee of the Mouse Models of Human Cancers Consortium. Kogan SC, et al. Blood. 2002 Jul 1;100(1):238-45. doi: 10.1182/blood.v100.1.238. Blood. 2002. PMID: 12070033
• The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
  Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. Harris NL, et al. Histopathology. 2000 Jan;36(1):69-86. doi: 10.1046/j.1365-2559.2000.00895.x. Histopathology. 2000. PMID: 10632755
• The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
  Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. Harris NL, et al. Mod Pathol. 2000 Feb;13(2):193-207. doi: 10.1038/modpathol.3880035. Mod Pathol. 2000. PMID: 10697278
• Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.
  Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J. Harris NL, et al. Ann Oncol. 2000;11 Suppl 1:3-10. Ann Oncol. 2000. PMID: 10707771 Review.
• Hematopathology: integration of morphologic features and biologic markers for diagnosis.
  Jaffe ES. Jaffe ES. Mod Pathol. 1999 Feb;12(2):109-15. Mod Pathol. 1999. PMID: 10071336 Review.

Cited by

• Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma.
  Beachy SH, Onozawa M, Chung YJ, Slape C, Bilke S, Francis P, Pineda M, Walker RL, Meltzer P, Aplan PD. Beachy SH, et al. Blood. 2012 Aug 2;120(5):1048-59. doi: 10.1182/blood-2012-01-401760. Epub 2012 Jun 21. Blood. 2012. PMID: 22723554 Free PMC article.
• Initially disadvantaged, TEL-AML1 cells expand and initiate leukemia in response to irradiation and cooperating mutations.
  Li M, Jones L, Gaillard C, Binnewies M, Ochoa R, Garcia E, Lam V, Wei G, Yang W, Lobe C, Hermiston M, Passegué E, Kogan SC. Li M, et al. Leukemia. 2013 Jul;27(7):1570-3. doi: 10.1038/leu.2013.15. Epub 2013 Jan 16. Leukemia. 2013. PMID: 23443342 Free PMC article. No abstract available.
• Silencing of Testin expression is a frequent event in spontaneous lymphomas from Trp53-mutant mice.
  Weeks RJ, Ludgate JL, Le Mée G, Khanal R, Mehta S, Williams G, Slatter TL, Braithwaite AW, Morison IM. Weeks RJ, et al. Sci Rep. 2020 Oct 1;10(1):16255. doi: 10.1038/s41598-020-73229-3. Sci Rep. 2020. PMID: 33004921 Free PMC article.
• Anaplastic plasmacytoma of mouse--establishing parallels between subtypes of mouse and human plasma cell neoplasia.
  de Jong D, Janz S. de Jong D, et al. J Pathol. 2010 Jul;221(3):242-7. doi: 10.1002/path.2714. J Pathol. 2010. PMID: 20527018 Free PMC article.
• Irradiated Blm-deficient mice are a highly tumor prone model for analysis of a broad spectrum of hematologic malignancies.
  Warren M, Chung YJ, Howat WJ, Harrison H, McGinnis R, Hao X, McCafferty J, Fredrickson TN, Bradley A, Morse HC 3rd. Warren M, et al. Leuk Res. 2010 Feb;34(2):210-20. doi: 10.1016/j.leukres.2009.06.007. Epub 2009 Aug 25. Leuk Res. 2010. PMID: 19709744 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)